Search Results - "Lothe, Ragnhild"

Refine Results
  1. 1

    Biomarker-guided therapy for colorectal cancer: strength in complexity by Sveen, Anita, Kopetz, Scott, Lothe, Ragnhild A.

    Published in Nature reviews. Clinical oncology (01-01-2020)
    “…The number of molecularly stratified treatment options available to patients with colorectal cancer (CRC) is increasing, with a parallel rise in the use of…”
    Get full text
    Journal Article
  2. 2

    CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models by Eide, Peter W., Bruun, Jarle, Lothe, Ragnhild A., Sveen, Anita

    Published in Scientific reports (30-11-2017)
    “…Colorectal cancers (CRCs) can be divided into four gene expression-based biologically distinct consensus molecular subtypes (CMS). This classification provides…”
    Get full text
    Journal Article
  3. 3

    Portrait of the PI3K/AKT pathway in colorectal cancer by Danielsen, Stine Aske, Eide, Peter Wold, Nesbakken, Arild, Guren, Tormod, Leithe, Edward, Lothe, Ragnhild A.

    Published in Biochimica et biophysica acta (01-01-2015)
    “…PI3K/AKT signaling leads to reduced apoptosis, stimulates cell growth and increases proliferation. Under normal conditions, PI3K/AKT activation is tightly…”
    Get full text
    Journal Article
  4. 4

    Combination therapies with HSP90 inhibitors against colorectal cancer by Kryeziu, Kushtrim, Bruun, Jarle, Guren, Tormod K., Sveen, Anita, Lothe, Ragnhild A.

    “…Oncogene stability and homeostasis mediated by the HSP90 chaperone is a crucial protection trait of cancer cells. Therefore, HSP90 represents an attractive…”
    Get full text
    Journal Article
  5. 5

    Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies by Berg, Kaja C G, Eide, Peter W, Eilertsen, Ina A, Johannessen, Bjarne, Bruun, Jarle, Danielsen, Stine A, Bjørnslett, Merete, Meza-Zepeda, Leonardo A, Eknæs, Mette, Lind, Guro E, Myklebost, Ola, Skotheim, Rolf I, Sveen, Anita, Lothe, Ragnhild A

    Published in Molecular cancer (06-07-2017)
    “…Colorectal cancer (CRC) cell lines are widely used pre-clinical model systems. Comprehensive insights into their molecular characteristics may improve model…”
    Get full text
    Journal Article
  6. 6

    Spatial analysis and CD25-expression identify regulatory T cells as predictors of a poor prognosis in colorectal cancer by Bergsland, Christian H., Jeanmougin, Marine, Moosavi, Seyed H., Svindland, Aud, Bruun, Jarle, Nesbakken, Arild, Sveen, Anita, Lothe, Ragnhild A.

    Published in Modern pathology (01-09-2022)
    “…Regulatory T cells (Tregs) are a heterogeneous cell population that can either suppress or stimulate immune responses. Tumor-infiltrating Tregs are associated…”
    Get full text
    Journal Article
  7. 7

    Multifocal Primary Prostate Cancer Exhibits High Degree of Genomic Heterogeneity by Løvf, Marthe, Zhao, Sen, Axcrona, Ulrika, Johannessen, Bjarne, Bakken, Anne Cathrine, Carm, Kristina Totland, Hoff, Andreas M., Myklebost, Ola, Meza-Zepeda, Leonardo A., Lie, A. Kathrine, Axcrona, Karol, Lothe, Ragnhild A., Skotheim, Rolf I.

    Published in European urology (01-03-2019)
    “…Most primary prostate cancers are multifocal with individual tumors harboring different aggressiveness; however, the genomic heterogeneity among these tumors…”
    Get full text
    Journal Article
  8. 8

    'High proliferative cribriform prostate cancer' defines a patient subgroup with an inferior prognosis by Bogaard, Mari, Skotheim, Rolf I, Maltau, Aase V, Kidd, Susanne G, Lothe, Ragnhild A, Axcrona, Karol, Axcrona, Ulrika

    Published in Histopathology (01-12-2023)
    “…A cribriform pattern, reactive stroma (RS), PTEN, Ki67 and ERG are promising prognostic biomarkers in primary prostate cancer (PCa). We aim to determine the…”
    Get full text
    Journal Article
  9. 9
  10. 10

    GRIN3A: A biomarker associated with a cribriform pattern and poor prognosis in prostate cancer by Bogaard, Mari, Strømme, Jonas M., Kidd, Susanne G., Johannessen, Bjarne, Bakken, Anne C., Lothe, Ragnhild A., Axcrona, Karol, Skotheim, Rolf I., Axcrona, Ulrika

    Published in Neoplasia (New York, N.Y.) (01-09-2024)
    “…Prostate cancer with a cribriform pattern, including invasive cribriform carcinoma (ICC) and/or intraductal carcinoma (IDC) is associated with a poor…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Co-occurring mutations identify prognostic subgroups of microsatellite stable colorectal cancer by Nunes, Luís, Stenersen, Jakob Mørkved, Kryeziu, Kushtrim, Sjöblom, Tobias, Glimelius, Bengt, Lothe, Ragnhild A., Sveen, Anita

    Published in Molecular cancer (25-11-2024)
    “…Co-occurring mutations in pairs of genes can pinpoint clinically relevant subgroups of cancer. Most colorectal cancers (CRCs) are microsatellite stable (MSS)…”
    Get full text
    Journal Article
  13. 13

    Somatic mutations reveal complex metastatic seeding from multifocal primary prostate cancer by Carm, Kristina T., Johannessen, Bjarne, Bogaard, Mari, Bakken, Anne Cathrine, Maltau, Aase V., Hoff, Andreas M., Axcrona, Ulrika, Axcrona, Karol, Lothe, Ragnhild A., Skotheim, Rolf I.

    Published in International journal of cancer (01-03-2023)
    “…Primary prostate cancer shows a striking intraorgan molecular heterogeneity, with multiple spatially separated malignant foci in the majority of patients…”
    Get full text
    Journal Article
  14. 14

    Long noncoding RNA MIR31HG is a bona fide prognostic marker with colorectal cancer cell‐intrinsic properties by Eide, Peter W., Eilertsen, Ina A., Sveen, Anita, Lothe, Ragnhild A.

    Published in International journal of cancer (01-06-2019)
    “…Elevated miR‐31 expression is associated with poor outcome in colorectal cancer (CRC). Whether the prognostic information is independent of known molecular…”
    Get full text
    Journal Article
  15. 15
  16. 16

    MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer by Cekaite, Lina, Eide, Peter W, Lind, Guro E, Skotheim, Rolf I, Lothe, Ragnhild A

    Published in Oncotarget (09-02-2016)
    “…Gene expression is in part regulated by microRNAs (miRNAs). This review summarizes the current knowledge of miRNAs in colorectal cancer (CRC); their role as…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Oncogenicity of the Developmental Transcription Factor Sox9 by MATHEU, Ander, COLLADO, Manuel, SKOTHEIM, Rolf I, LOTHE, Ragnhild A, DE MUNAIN, Adolfo López, BRISCOE, James, SERRANO, Manuel, LOVELL-BADGE, Robin, WISE, Clare, MANTEROLA, Lorea, CEKAITE, Lina, TYE, Angela J, CANAMERO, Marta, BUJANDA, Luis, SCHEDL, Andreas, CHEAH, Kathryn S. E

    Published in Cancer research (Chicago, Ill.) (01-03-2012)
    “…SOX9 [sex-determining region Y (SRY)-box 9 protein], a high mobility group box transcription factor, plays critical roles during embryogenesis and its activity…”
    Get full text
    Journal Article
  19. 19
  20. 20